We are live on ! Find out more
BN

Bill Nygren Harris Associates

AUM $75.4B
1-Year Est. Return 14.46%
 

Bill Nygren is a portfolio manager at Harris Associates and a long-time lead voice behind the Oakmark family of funds. He is known for a value philosophy that seeks growing businesses at discounts to intrinsic value rather than statistically cheap “cigar butts” alone. Nygren’s shareholder letters are popular for clear explanations of valuation, portfolio changes, and long-term equity ownership.

This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+14.46%
3 Year Est. Return
+51.56%
5 Year Est. Return
+71.24%
10 Year Est. Return
+347.3%
AUM
$64.4B
AUM Growth
+$3.5B
Cap. Flow
+$96M
Cap. Flow %
0.15%
Top 10 Hldgs %
33.79%
Holding
185
New
10
Increased
74
Reduced
76
Closed
3

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$798M
2
FDX icon
FedEx
FDX
+$512M
3
GD icon
General Dynamics
GD
+$352M
4
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$318M
5
LH icon
Labcorp
LH
+$287M

Sector Composition

Rank Sector Weight
1 Financials 35.51%
2 Technology 17.58%
3 Consumer Discretionary 15.02%
4 Industrials 8.03%
5 Healthcare 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
151
PepsiCo
PEP
$196B
$747K ﹤0.01%
7,902
+200
+3% +$19.2K
MHFI
152
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$712K ﹤0.01%
8,000
DHR icon
153
Danaher
DHR
$154B
$540K ﹤0.01%
9,373
PG icon
154
Procter & Gamble
PG
$336B
$520K ﹤0.01%
5,709
ADM icon
155
Archer Daniels Midland
ADM
$38.7B
$471K ﹤0.01%
9,050
MBFI
156
DELISTED
MB Financial Corp
MBFI
$459K ﹤0.01%
13,969
-4,200
-23% -$128K
MO icon
157
Altria Group
MO
$110B
$432K ﹤0.01%
8,762
+180
+2% +$8.77K
K
158
DELISTED
Kellanova
K
$419K ﹤0.01%
6,816
SLB icon
159
SLB Ltd
SLB
$79.9B
$419K ﹤0.01%
4,900
+2,100
+75% +$193K
KS
160
DELISTED
KapStone Paper and Pack Corp.
KS
$416K ﹤0.01%
14,200
ALL icon
161
Allstate
ALL
$64.2B
$415K ﹤0.01%
5,907
-1,084
-16% -$71.3K
CVX icon
162
Chevron
CVX
$403B
$411K ﹤0.01%
3,668
+600
+20% +$68.2K
GNRC icon
163
Generac Holdings
GNRC
$12.2B
$411K ﹤0.01%
+8,800
New +$385K
AMGN icon
164
Amgen
AMGN
$238B
$401K ﹤0.01%
2,519
-518
-17% -$80.7K
CDK
165
DELISTED
CDK Global, Inc.
CDK
$387K ﹤0.01%
+9,491
New +$336K
PSX icon
166
Phillips 66
PSX
$96.9B
$380K ﹤0.01%
5,300
HON icon
167
Honeywell
HON
$68.4B
$357K ﹤0.01%
3,972
LLTC
168
DELISTED
Linear Technology Corp
LLTC
$319K ﹤0.01%
7,000
CNI icon
169
Canadian National Railway
CNI
$78.5B
$310K ﹤0.01%
4,500
PCL
170
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$291K ﹤0.01%
6,800
BAX icon
171
Baxter International
BAX
$13.6B
$279K ﹤0.01%
6,996
-3,053,501
-100% -$119M
CSCO icon
172
Cisco
CSCO
$438B
$278K ﹤0.01%
+10,000
New +$258K
LLY icon
173
Eli Lilly
LLY
$1.12T
$263K ﹤0.01%
3,810
+110
+3% +$7.42K
AET
174
DELISTED
Aetna Inc
AET
$259K ﹤0.01%
2,920
ESRX
175
DELISTED
Express Scripts Holding Company
ESRX
$257K ﹤0.01%
3,035
-2,889
-49% -$226K

Similar funds

Bill Nygren's Q4 2014 Portfolio in Review

As of Q4 2014, Bill Nygren held 185 positions worth $64.4B, up 5.7% from $60.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Bill Nygren's Q4 2014 filing shows 10 new, 74 increased, 76 reduced and 3 closed positions. Its largest new stake was Chesapeake Energy Corporation: 143,802 shares worth $563M. The largest sale was Oracle, an estimated $798M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Bill Nygren's largest Q4 2014 buy was Chesapeake Energy Corporation: 143,802 shares worth $563M.
  • Bill Nygren added most to APA Corp in Q4 2014, an estimated $643M increase.
  • Bill Nygren's biggest Q4 2014 reduction was Oracle, cutting an estimated $798M.
  • Bill Nygren fully exited Varian Medical Systems, Inc. in Q4 2014, selling an estimated $53.9M.
  • Bill Nygren's ten largest holdings make up 34% of its $64.4B portfolio in Q4 2014.
  • Bill Nygren opened 10 new positions and closed 3 in Q4 2014.
  • Bill Nygren's portfolio value rose 5.7% quarter-over-quarter to $64.4B.

Based on Harris Associates's 13F filing for Q4 2014, filed 23 Jan 2015.